We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GAIL:NSEGAIL (India) Limited Analysis

Data as of 2026-06-21 - not real-time

₹174.10

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

GAIL (India) Limited is trading at ₹174.1, comfortably above its 20‑day (₹169.19), 50‑day (₹164.61) and 200‑day (₹167.86) moving averages, with a bullish MACD crossover and a RSI of 61 indicating continued momentum without being overbought. The stock offers an attractive 7.19% dividend yield and a modest payout ratio of 52%, supported by solid operating cash flow and a free cash flow generation of ₹12.97 bn. Valuation metrics are compelling: a trailing PE of 15 versus the industry average of 20, and a forward PE of just 9.75, suggesting the market is pricing in upside potential of roughly 5.4% to the consensus target of ₹183.45. However, the balance sheet shows a high debt‑to‑equity ratio of 27.8, though cash reserves of ₹21.27 bn and a low beta of 0.38 mitigate immediate financial stress.
The 30‑day volatility of 27% and decreasing volume hint at a cautious market environment, yet the regulated utilities sector provides stable cash flows and limited sector risk. With a forward EPS outlook improving to ₹17.85 and ongoing diversification into renewable energy, GAIL appears positioned for steady, dividend‑driven returns while the current price reflects a modest undervaluation relative to peers.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above key moving averages and bullish MACD
  • High dividend yield with sustainable payout
  • Undervalued relative to industry PE

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward PE of 9.75 indicating strong earnings upside
  • Stable regulated gas business supporting cash flow
  • Consensus target price provides ~6% upside

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Long‑term natural gas demand and renewable expansion
  • High debt level warrants monitoring
  • Consistent dividend income and low beta reduce volatility

Key Metrics & Analysis

Financial Health

Revenue Growth-2.40%
Profit Margin5.36%
P/E Ratio15.1
ROE8.69%
ROA3.50%
Debt/Equity27.81
P/B Ratio1.3
Op. Cash Flow₹112.5B
Free Cash Flow₹13.0B
Industry P/E20.6

Technical Analysis

TrendNeutral
RSI61.3
Support₹161.18
Resistance₹178.20
MA 20₹169.19
MA 50₹164.61
MA 200₹167.86
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Target Price₹183.45
Upside/Downside5.37%
GradeUndervalued
TypeBlend
Dividend Yield7.19%

Risk Assessment

Beta0.38
Volatility27.35%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.